Venus Remedies Limited (VENUSREM.NS)

INR 323.55

(-0.75%)

Market Cap (In INR)

4.32 Billion

Revenue (In INR)

5.91 Billion

Net Income (In INR)

284.9 Million

Avg. Volume

68.19 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
281.1-430.0
PE
-
EPS
-
Beta Value
1.062
ISIN
INE411B01019
CUSIP
Y93612110
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Ashutosh Jain B.A., LL.B
Employee Count
-
Website
https://www.venusremedies.com
Ipo Date
2006-12-20
Details
Venus Remedies Limited develops and markets pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, such as analgesic, analgesic and antipyretic, anti-diabetic, antibiotic, anticoagulant, cardiac, disinfectant and antiseptic, gastro therapy, hand sanitizers, hormones, iron supplements, neurology, oncology, pain management, respiratory, skin and wound care, stress reliever, urology, and vitamins/minerals/nutrients, as well as antimicrobial resistance products. It also provides disinfectants; and a portfolio of herbal products. Venus Remedies Limited was incorporated in 1989 and is headquartered in Panchkula, India.